Cargando...

A product of independent beta probabilities dose escalation design for dual-agent phase I trials

Dual-agent trials are now increasingly common in oncology research, and many proposed dose-escalation designs are available in the statistical literature. Despite this, the translation from statistical design to practical application is slow, as has been highlighted in single-agent phase I trials, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stat Med
Autores principales: Mander, Adrian P, Sweeting, Michael J
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409822/
https://ncbi.nlm.nih.gov/pubmed/25630638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6434
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!